Advertisement
Advertisement

GH

GH logo

Guardant Health, Inc. Common Stock

90.36
USD
Sponsored
+4.66
+5.44%
Apr 17, 16:00 UTC -4
Closed
exchange

After-Market

92.00

+1.64
+1.81%

Guardant Health, Inc. Common Stock Profile

About

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.

Info & Links

CEO

Helmy Eltoukhy

Headquarters

3100 Hanover Street
Palo Alto, CA 94304, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.guardanthealth.com

Auditor

Deloitte & Touche LLP

Share holders

56

Employees

2,506

Guardant Health, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

12.07B

Enterprise Value

13.19B

Enterprise Value/EBITDA(ttm)

-32.71

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

11.64

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

64.41%

Operating Margin(ttm)

-42.26%

Profit Margin(ttm)

-42.62%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-44.67%

Return on Assets(ttm)

-27.82%

Income Statement

Revenue(ttm)

982.02M

Revenue Per Share(ttm)

7.49

Gross Profit(ttm)

633.01M

EBITDA(ttm)3

-403.39M

Net Income Available to Common(ttm)

-416.28M

Diluted EPS(ttm)

-3.31

Share Statistics

Beta (5Y Monthly)

1.64

52-Week Change

100.93%

S&P 500 52-Week Change

38.15%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

131.17M

Dividend Yield

0.00%

Float4

123.17M

% Held by Insiders

6.10%

% Held by Institutions

92.60%

Balance Sheet

Total Cash(mrq)

1.20B

Total Cash Per Share(mrq)

9.16

Total Debt(mrq)

1.50B

Total Debt/Equity(mrq)

-1514.50%

Current Ratio(mrq)

4.84%

Quick Ratio(mrq)

4.56%

Book Value Per Share(mrq)

-0.76

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.47

Free Cash Flow(ytd)

-233.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement